Drugs / 177Lu-NYM096
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06649682 | Nov 2024 → Oct 2026 | clear cell renal carcinoma | Peking Union Medical College Hospital | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 177Lu-NYM096 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06649682 ↗ |